Literature DB >> 24239405

Amino ozonides exhibit in vitro activity against Echinococcus multilocularis metacestodes.

Tatiana Küster1, Nadja Kriegel1, Britta Stadelmann1, Xiaofang Wang2, Yuxiang Dong2, Jonathan L Vennerstrom2, Jennifer Keiser3, Andrew Hemphill4.   

Abstract

Artemisinin is an antimalarial sesquiterpene lactone that contains a 1,2,4-trioxane heterocycle. Dihydroartemisinin and artesunate demonstrated activity against Echinococcus multilocularis metacestodes in vitro but were not effective in a mouse model. In this study, the in vitro effects of a small library of synthetic ozonides (1,2,4-trioxolanes) were investigated. Initial compound screening against E. multilocularis metacestodes was performed at 20μM, and selected ozonides were further assessed in dose-response studies in metacestode cultures and mammalian cells. Transmission electron microscopy (TEM) was employed to characterise compound-induced structural alterations. At 20μM, the most potent ozonides (OZ401, OZ455, OZ491 and OZ494) led to death of ca. 60-100% of the parasites. Subsequent dose-response experiments demonstrated that OZ401, OZ455 and OZ491, which contain an aminopropylether substructure, were the most potent, with 50% inhibitory concentrations ranging from 11μM to 14μM. Cytotoxicity for these three ozonides, assessed in human foreskin fibroblasts, rat hepatoma cells and green monkey epithelial kidney (Vero) cells, was evident only at high concentrations. TEM demonstrated that OZ401 and OZ491 treatment induced considerable metabolic impairment in metacestodes at 1 day post exposure. At Day 3 post exposure, the germinal layer was severely distorted, although some intact cells were still visible, demonstrating that not all cell types in the parasite tissue were equally affected. Complete destruction of the germinal layer was noted at 5 days post exposure. Synthetic ozonides could represent interesting leads that will be further investigated in a suitable in vivo model of E. multilocularis infection.
Copyright © 2013 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Keywords:  Artemisinin; Chemotherapy; Echinococcus multilocularis; Synthetic peroxides; Transmission electron microscopy

Mesh:

Substances:

Year:  2013        PMID: 24239405     DOI: 10.1016/j.ijantimicag.2013.09.012

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  12 in total

Review 1.  Drug target identification in protozoan parasites.

Authors:  Joachim Müller; Andrew Hemphill
Journal:  Expert Opin Drug Discov       Date:  2016-06-16       Impact factor: 6.098

2.  Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: Compounds and therapeutic targets.

Authors:  Mar Siles-Lucas; Adriano Casulli; Roberto Cirilli; David Carmena
Journal:  PLoS Negl Trop Dis       Date:  2018-04-20

3.  Pharmacokinetics of the Antischistosomal Lead Ozonide OZ418 in Uninfected Mice Determined by Liquid Chromatography-Tandem Mass Spectrometry.

Authors:  Anna Leonidova; Mireille Vargas; Jörg Huwyler; Jennifer Keiser
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

4.  Profound activity of the anti-cancer drug bortezomib against Echinococcus multilocularis metacestodes identifies the proteasome as a novel drug target for cestodes.

Authors:  Britta Stadelmann; Denise Aeschbacher; Cristina Huber; Markus Spiliotis; Joachim Müller; Andrew Hemphill
Journal:  PLoS Negl Trop Dis       Date:  2014-12-04

Review 5.  Treatment of echinococcosis: albendazole and mebendazole--what else?

Authors:  Andrew Hemphill; Britta Stadelmann; Reto Rufener; Markus Spiliotis; Ghalia Boubaker; Joachim Müller; Norbert Müller; Daniela Gorgas; Bruno Gottstein
Journal:  Parasite       Date:  2014-12-22       Impact factor: 3.000

6.  Screening of the Open Source Malaria Box Reveals an Early Lead Compound for the Treatment of Alveolar Echinococcosis.

Authors:  Britta Stadelmann; Reto Rufener; Denise Aeschbacher; Markus Spiliotis; Bruno Gottstein; Andrew Hemphill
Journal:  PLoS Negl Trop Dis       Date:  2016-03-11

7.  The effects of taxanes, vorinostat and doxorubicin on growth and proliferation of Echinococcus multilocularis metacestodes assessed with magnetic resonance imaging and simultaneous positron emission tomography.

Authors:  Xiangsheng Huang; Stefan Wiehr; Anna-Maria Wild; Patrick Voßberg; Wolfgang Hoffmann; Beate Grüner; Carsten Köhler; Peter T Soboslay
Journal:  Oncotarget       Date:  2018-01-10

8.  Drug repurposing applied: Activity of the anti-malarial mefloquine against Echinococcus multilocularis.

Authors:  Britta Lundström-Stadelmann; Reto Rufener; Andrew Hemphill
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2020-07-02       Impact factor: 4.077

9.  Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis.

Authors:  Reto Rufener; Dominic Ritler; Jana Zielinski; Luca Dick; Emerson Teixeira da Silva; Adriele da Silva Araujo; Deborah Elisabeth Joekel; David Czock; Christine Goepfert; Adriana Marques Moraes; Marcus Vinicius Nora de Souza; Joachim Müller; Meike Mevissen; Andrew Hemphill; Britta Lundström-Stadelmann
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2018-06-15       Impact factor: 4.077

10.  Cyclic Synthetic Peroxides Inhibit Growth of Entomopathogenic Fungus Ascosphaera apis without Toxic Effect on Bumblebees.

Authors:  Ivan A Yaremenko; Mikhail Y Syromyatnikov; Peter S Radulov; Yulia Yu Belyakova; Dmitriy I Fomenkov; Vasily N Popov; Alexander O Terent'ev
Journal:  Molecules       Date:  2020-04-22       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.